Single Incision Laparoscopic Surgery Market Report 2025

The single-incision laparoscopic surgery market size has grown rapidly in recent years. It will grow from $2.8 billion in 2024 to $3.08 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to the rising adoption of minimally invasive procedures, an increasing geriatric population requiring surgical interventions, the growing prevalence of gastrointestinal and bariatric disorders, the expansion of ambulatory surgical centers, and the increasing patient preference for faster recovery options.

The single-incision laparoscopic surgery market size is expected to see strong growth in the next few years. It will grow to $4.48 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to the increasing demand for outpatient surgical procedures, rising healthcare expenditure in emerging economies, growing focus on cost-effective surgical solutions, expansion of specialized surgical training programs, and the increasing prevalence of obesity-related surgeries. Key trends expected during this period include technological advancements, product innovations, development of ergonomic surgical instruments, greater investment in research and development, and improvements in imaging and visualization systems.

The increasing preference for minimally invasive procedures is expected to drive the growth of the single incision laparoscopic surgery (SILS) market in the coming years. Minimally invasive procedures involve medical or surgical techniques performed through small incisions or natural openings to reduce tissue damage, pain, and recovery time. Their popularity is growing because they lead to faster recovery, less discomfort, and shorter hospital stays. SILS further minimizes invasiveness by using a single small entry point, which reduces tissue trauma, resulting in less pain, quicker healing, and fewer scars compared to traditional multi-port surgeries. For example, in August 2023, The Aesthetic Society, a U.S.-based organization for plastic surgery and cosmetic medicine, reported that Americans spent over $11.8 billion on aesthetic procedures, a 2% increase from the previous year. Consequently, the rising preference for minimally invasive procedures is boosting the single incision laparoscopic surgery market.

Companies in the SILS market are focusing on innovations such as single-port robotic surgery to improve surgical precision and expand the range of minimally invasive procedures. Single-port robotic surgery uses robotic systems to perform operations through a single small incision, offering enhanced accuracy and faster patient recovery. For instance, in April 2025, Intuitive Surgical, Inc., a U.S.-based provider of minimally invasive technology, received FDA clearance for the SureForm 45 stapler. Designed for use with the da Vinci SP surgical system in urologic, thoracic, and colorectal procedures, it features SmartFire technology, which continuously monitors tissue compression during stapling to optimize staple line integrity and reduce tissue damage. The device allows surgeons to control stapling from the console, reducing the need for an assistant while using wristed instruments and a 3D camera to minimize instrument collisions in confined surgical spaces.

In November 2024, Medtronic plc, an Ireland-based medical technology company, acquired Fortimedix Surgical B.V. for an undisclosed sum. This acquisition enables Medtronic to expand its surgical and endoscopy portfolio by incorporating Fortimedix’s laser-cut articulating instruments, strengthening its capabilities in minimally invasive and robotic-assisted surgeries, and supporting the development of its Hugo soft-tissue robotic system. Fortimedix Surgical B.V., based in the Netherlands, specializes in minimally invasive surgery and offers a single-port laparoscopic surgery platform.

Major players in the single incision laparoscopic surgery market are Medtronic plc, Fujifilm Holdings Corporation, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Arthrex Inc., Karl Storz SE & Co. KG, Cook Medical Inc., Applied Medical Resources Corporation, Burjeel Hospital, Fortis Healthcare Limited, Richard Wolf GmbH, Peters Surgical, Geyi Medical Instrument, Levita Magnetics, Millennium Surgical Corp., Asensus Surgical Inc., Surtex Instruments Limited.

North America was the largest region in the single incision laparoscopic surgeries market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in single-incision laparoscopic surgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the single-incision laparoscopic surgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Single incision laparoscopic surgery (SILS) is a minimally invasive procedure in which surgeons operate through a single entry point, usually the navel, using specialized instruments and a laparoscope. This technique offers cosmetic advantages with nearly scar-free results, while also promoting faster recovery, reduced postoperative pain, and a lower risk of complications compared to traditional multi-port laparoscopic surgery.

The primary types of products used in single-incision laparoscopic surgery include surgical instruments, access devices, closure devices, and others. Surgical instruments are precision tools designed to perform operations through a single small incision, minimizing tissue damage. SILS is employed in various procedures such as cholecystectomy, appendectomy, colectomy, hernia repair, bariatric surgery, and more. These products are utilized by a wide range of end users, including hospitals, ambulatory surgical centers, specialty clinics, and other healthcare facilities.

The single incision laparoscopic surgery market research report is one of a series of new reports that provides single incision laparoscopic surgery market statistics, including single incision laparoscopic surgery industry global market size, regional shares, competitors with a single incision laparoscopic surgery market share, detailed single incision laparoscopic surgery market segments, market trends and opportunities, and any further data you may need to thrive in the single incision laparoscopic surgery industry. This single incision laparoscopic surgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The single-incision laparoscopic surgery market consists of revenues earned by entities by providing services such as diagnostic laparoscopy, nephrectomy, splenectomy, and hysterectomy. The market value includes the value of related goods sold by the service provider or included within the service offering. The single-incision laparoscopic surgeries market also includes sales of insufflation systems, laparoscopes, suturing and stapling devices, single-use or reusable trocar systems, and training simulators and kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.